Advancements in the Diagnostics and Therapeutics for Non-Small Cell Lung Carcinoma (NSCLC)

Non-small cell lung carcinoma (NSCLC) remains the most prevalent subtype of lung cancer, representing a significant global health burden. Over the past decade, rapid advancements in both diagnostics and treatment have transformed the clinical landscape, shifting to a more personalized approach and precision-based strategies. Innovations in imaging have enhanced early detection and accurate tumor characterization, while breakthroughs in targeted treatments and combination regimens have significantly improved patient outcomes. These developments reshape disease management and offer renewed hope for patients. Advancements in the Diagnostics and Therapeutics for Non-Small Cell Lung Carcinoma (NSCLC) explores current research and clinical practices in diagnostics, therapeutics, and patient care management. It examines the rapid evolution of treatment options, providing up-to-date and comprehensive educational resources for clinicians and healthcare providers. Covering topics such as surgical management, immunology, and chemotherapy, this book is an excellent resource for oncologists, medical and healthcare professionals, researchers, and scientists.